At just 43, Oliver was diagnosed with prostate cancer after a routine NHS blood test revealed he had an elevated prostate specific antigen (PSA) level. As his cancer began to progress, Oliver faced difficult decisions about his treatment.
Thankfully, he was offered the chance to take part in a cutting-edge clinical trial, which is supported by The Royal Marsden Cancer Charity thanks to the generous donations of supporters like you.
In June 2025, Oliver became the first patient in Europe to undergo aquablation therapy on the trial – a minimally invasive, robotic-assisted surgical technique.
Understanding his diagnosis
“Due to my family history, I’ve always paid attention to my PSA levels. Cancer has affected a lot of people in my family, as we carry the BRCA gene mutation, so it’s something we’ve always talked openly about.
“When my PSA came back elevated, I had further investigations. My diagnosis was later confirmed at The Royal Marsden, and I was placed on active surveillance. Looking back, that decision to follow things up probably changed the course of my life.”
What are PSA levels and BRCA gene mutations?
PSA (prostate-specific antigen) is a protein produced by the prostate gland. A blood test can measure PSA levels, and an elevated result can be an indication of prostate cancer, although there are other possible causes. Further investigations are usually needed to establish what is happening.
BRCA1 and BRCA2 are genes that help protect the body against cancer by repairing damaged DNA. Inherited changes (mutations) in these genes can increase the risk of developing certain cancers, including prostate cancer. Understanding family history and genetic risk can help inform conversations about screening and monitoring.

“From my very first appointment at The Royal Marsden, I felt that I was treated as an individual. The expertise sat with the team caring for me, but my views mattered too. I always felt involved in decisions about my care.
“Everything remained stable for years. I carried on working, carried on being a husband and a dad, and carried on getting on with life. However, at the beginning of 2024, things started to change.
“My PSA levels began to rise and my annual MRI scans showed the cancer was growing. I had a couple of biopsies for the team to take a closer look. The conversations then shifted from monitoring the cancer to deciding how best to treat it.”
The standard treatment option for Oliver was a prostatectomy – surgery to remove the prostate.
“I was too young to be dealing with any surgery and treatment that would render me impotent and incontinent. But in terms of the hierarchy of need, being alive outweighed either of these things.”
Taking part in pioneering cancer research
After detailed discussions with the research team, Oliver decided to take part in the Water IV PCa trial, which is supported by funding from The Royal Marsden Cancer Charity.
The trial is investigating aquablation therapy, an innovative technique designed to treat cancer while reducing the risk of life-altering side effects such as incontinence and impotence. Aquablation therapy uses a robotic, high-pressure waterjet that allows surgeons to map the entire prostate in real time with ultrasound, delivering precise treatment that is less invasive than traditional surgery.

“The aquablation treatment was carried out in June 2025. I was first person in Europe to have this procedure as part of the trial.
“I stayed in hospital for several days afterwards. I’ll never forget waking up after the procedure and seeing my consultant, Mr Charlesworth, come over to speak to me. He was genuinely delighted!
“He told me the procedure had gone really well and that he was very pleased with the outcome. It was incredibly reassuring to hear that while I was still recovering.”
Recovery and results
“The first few weeks of recovery weren’t always easy. There were some bumps in the road, which I’d been warned about, and a few occasions where I needed extra support and advice. But throughout that time I always felt looked after.
“Four weeks after the procedure, I returned for follow-up appointments and tests. The results were better than anyone had hoped. My PSA levels had dropped to almost undetectable levels, and MRI scans showed that all the cancer had been removed. It was an enormous relief.”
Why cancer research matters
“Research gave me another option. Without that trial, I would have been facing a much more invasive procedure. Instead, I was able to access something innovative that may help shape future treatment for other patients. That’s why research matters.
“If the information gathered from my experience helps my sons, friends or someone I’ll never meet, then that’s incredibly worthwhile.
“The care at The Royal Marsden has been magnificent. Every member of staff has been professional, compassionate and clear about what they’re doing and why."
Running the Paris Marathon to say thank you
“After my treatment, I started thinking about how I could give something back. I’d received such incredible care from The Royal Marsden and I wanted to say thank you.
“I was having a check up and I saw a poster promoting running events for The Royal Marsden Cancer Charity. Next thing I knew, I was signed up to do the Paris Marathon!
“At the time, I didn’t know whether I’d be fit enough to complete it. I was still recovering from treatment and everything felt uncertain. But that became part of my motivation.
“Crossing the finish line was euphoric. I saw my family near the end of the course and hearing them say, ‘You’ve done it,’ meant everything to me. I’m still emotional thinking about it now.
“In the end, I raised almost £2,000 and it felt like a small way of saying thank you.”

"I can still do the precious ordinary things in life, thanks to the charity's supporters"
“When people ask me what The Royal Marsden means to me, I always come back to one thing. It’s given me confidence in the future.
“My youngest son summed it up perfectly. He said: ‘They’ve safeguarded our future.’ That’s exactly how it feels.
“The people here haven’t just looked after me. They’ve looked after my family too. Because of The Royal Marsden, I get more time with family.
“For donors supporting the Charity, I’d like to invite them all to a Saturday morning breakfast at my house. I’d like them to watch me do Parkrun with my children. I’d like them to witness me taking my wife out for dinner. I’d like them to know that all those things are nothing to do with material success in life, but to do with the ordinary precious and important things in life; and my ability to do all those things is thanks to them and their donations.”
“With funding on trials like mine, it’s a ripple effect. Donations enable the trial to happen in the first place. The results from clinical trials encourage stronger growth, stronger international reputation, stronger clinical excellence. It’s exponentially brilliant."
“If my story helps encourage someone to get checked, consider taking part in research or support the work of The Royal Marsden Cancer Charity, then sharing it is absolutely worth it.”
Support life-changing research
Thanks to the Water IV PCa trial, which is supported by The Royal Marsden Cancer Charity, Oliver is able to enjoy more time with the people he loves.
Your donations ensure The Royal Marsden can continue to develop new and better treatments for people with cancer, now and in the future.
Find out more about the ways you can support us today.
The trial has now completed recruitment and initial results are expected in 2027.
